Literature DB >> 17565515

Diagnosis and treatment of pheochromocytoma in urinary bladder.

Yong Liu1, Sheng-Guo Dong, Zhen Dong, Xin Mao, Xin-Yan Shi.   

Abstract

OBJECTIVE: To study the diagnosis and treatment of pheochromocytoma in urinary bladder.
METHODS: Six cases of bladder pheochromocytoma were studied. Four cases showed hypertension, 3 of which were paroxysmal hypertension during urination. Catecholamine (CA) was increased in a case, and vanillymandelic acid (VMA) was increased in 2 cases. Bladder submucosal mass was detected by B-ultrasound in 5 cases (5/5), computerized tomography (CT) in 3 cases (3/3), cystoscopy in 5 cases (5/6). Four cases took alpha-receptor blocker for 2 weeks, 1 case took beta-receptor blocker to decrease heart rate. All patients were treated with surgical operation including 4 partial cystectomies, 2 excavations.
RESULTS: Three cases had manifestations including headache, excessive perspiration and hypertension during cystoscopy. Four cases were confirmed before operation. Two cases showed hypertension during operation. All patients were pathologically diagnosed as pheochromocytoma postoperatively. In five cases followed up, blood pressure returned to normal. No patient had relapse and malignancy.
CONCLUSIONS: Typical hypertension during urination comprised the main symptoms. We should highly suspect bladder pheochromocytoma if a submucosal mass was discovered with B-ultrasound, CT, (131)I-MIBG (methyliodobenzylguanidine) and cystoscopy. The determination of CA in urine is valuable for qualitative diagnosis. The preoperative management of controlling blood pressure and expansion of the blood volume are very important. Surgical operation is a good method for effective treatment. Postoperative long-time followed up is necessary.

Entities:  

Mesh:

Year:  2007        PMID: 17565515      PMCID: PMC1879157          DOI: 10.1631/jzus.2007.B0435

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  5 in total

Review 1.  Pheochromocytoma of the urinary bladder: update on new diagnostic modalities plus case report.

Authors:  E Karpman; P Zvara; R Stoppacher; T L Jackson; M K Plante
Journal:  Ann Urol (Paris)       Date:  2000-02

2.  Phaeochromocytoma of the urinary bladder.

Authors:  I Naqiyah; M Rohaizak; F A Meah; M J Nazri; M Sundram; A R Amram
Journal:  Singapore Med J       Date:  2005-07       Impact factor: 1.858

3.  A case of bladder pheochromocytoma.

Authors:  N Seki; S Mukai; A Gamachi; T Migita; K Maeda; N Ogata
Journal:  Urol Int       Date:  2001       Impact factor: 2.089

4.  Bladder pheochromocytoma: a 3-year follow-up after transurethral resection (TURB).

Authors:  C Baima; G Casetta; R Vella; A Tizzani
Journal:  Urol Int       Date:  2000       Impact factor: 2.089

5.  Pheochromocytoma of the urinary bladder without typical symptoms.

Authors:  Takehisa Onishi; Yuko Sakata; Shigenori Yonemura; Yoshiki Sugimura
Journal:  Int J Urol       Date:  2003-07       Impact factor: 3.369

  5 in total
  4 in total

1.  Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes.

Authors:  Victoria L Martucci; Zarina G Lorenzo; Michael Weintraub; Jaydira del Rivero; Alexander Ling; Maria Merino; Minhaj Siddiqui; Brian Shuch; Srinivas Vourganti; W Marston Linehan; Piyush K Agarwal; Karel Pacak
Journal:  Urol Oncol       Date:  2015-02-13       Impact factor: 3.498

2.  Robotic management of pheochromocytoma of the vesicoureteric junction.

Authors:  Rishi Nayyar; Prabhjot Singh; Narmada P Gupta
Journal:  JSLS       Date:  2010 Apr-Jun       Impact factor: 2.172

3.  Degeneration of the symphysis pubis presenting as a submucosal urinary bladder tumour.

Authors:  Tomasz R Szopiński; Iwona Sudoł-Szopińska; Mariusz I Furmanek; Tomasz Dzik; Piotr L Chłosta; Andrzej Borówka
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2011-11-08       Impact factor: 1.195

4.  Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs.

Authors:  Musa Male; Tao Ye; Jin Tao; Zhi-Qiang Chen; Ejun Peng
Journal:  Biomed Res Int       Date:  2019-11-06       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.